English
GenoScreen supports the CINERGY project!
During the international competition iGEM (International Genetically Engineered Machine), GenoScreen supports the IGEM IONIS student team for its "Cinergy" project.
GenoScreen participates in the Adebiotech’s IDSA conference!
GenoScreen is a sponsor of the Adebiotech's conference on "Sustainable Inputs to Agricultural, Urban and Peri-Urban Soil Service (IDSA)", from 14 to 16 May 2019 at Biocitech Romainville-Grand Paris .
Meet us at the 7th International Molecular Diagnostics Europe.
Meet us at the Cambridge Healthtech Institute’s Seventh International Molecular Diagnostics Europe from May 6-8 in Lisbon.
World TB Day: GenoScreen participates to the International Tuberculosis Conference in Brussels!
On March 21st, GenoScreen will participate in the "International Conference on Tuberculosis" in Brussels.
GenoScreen finalizes a €1 million fundraising campaign to continue its international expansion
GenoScreen announced today that it has completed a €1 million fundraising campaign with private investors.
Pioneer company since 2001 in sequencing, genotyping and bioinformatics, GenoScreen provides innovative services and solutions in genomics to address the needs of academic and industrial research teams. At the forefront of genomics in France, GenoScreen develops innovation programs that fuel its technological lead and generate high-performance analytical, products and control services.
Meet us at BioFIT 2018!
On the 4th and 5th of December 2018, GenoScreen will participate at the 7th edition of the BioFIT business convention which will take place this year in Lille Grand Palais.
Improving, through the genomic approach, the diagnosis, monitoring and follow-up of polluted sites: the conclusions of the BioDISSPOL project
GenoScreen will present the conclusions of the BioDISSPOL project on November 28 at Pollutec Lyon during the panel discussion: "Microbial Biomarkers : Application to the diagnosis and management of polluted sites".
Subcategories
GenoScreen
Partners
At GenoScreen, our genomics expertise is built on collaboration with a dense network of scientific, industrial and institutional partners. These partnerships strengthen our ability to innovate, co-develop new technologies and advance research in molecular microbiology.
A network of strategic partners
We actively collaborate with:
Research institutes, universities and hospitals
Competitive clusters specialized in biotechnology and healthcare
Public funding bodies
A co-development strategy
Our research projects are carried out with recognized partners in France and abroad. Together, we can :
- Co-develop innovative genomics and bioinformatics solutions
- Reply to national and international applications for projects (Horizon Europe, ANR, etc.)
- Test and validate our technologies in a variety of environments
- Launch the implementation of concrete solutions for health, agriculture and the environment
Why collaborate with GenoScreen?
- Access to an innovative sequencing technology platform
- Access to recognized expertise in bioinformatics analysis and biomarkers
- Benefit from our ability to manage collaborative R&D projects
- Strive for health, agriculture and environment
Join our network of partners
Do you represent a company, laboratory or public body? Contact us to discuss a collaboration or partnership.
Frequently asked questions
What kind of partners work with GenoScreen?
GenoScreen works with academic laboratories, biotech companies and clusters.
What are the benefits of these partnerships?
They help us co-develop technologies, co-finance projects and accelerate innovation.
How can I propose a partnership?
You can contact us via our contact form to discuss your project and identify a potential collaboration.
Collaborative research - At the heart of international innovation in genomics
GenoScreen is a partner in collaborative research projects that bring together startups, multinationals and public-sector organizations. Our R&D teams provide their knowledge and expertise in the molecular microbiology of isolated agents and complex communities. This allowed our teams to develop our own projects for elaborating innovative products and services.
Our projects are designed to:
- Improve the diagnosis and management of acute/chronic diseases on humans and animals,
- Characterize and monitor microbial biodiversity, with applications in agronomy, agrifood and environment.
The common feature of these projects is the development of molecular tools for the characterization, monitoring and diagnosis of microbial communities. The key objective is to market simple analytical solutions and (ultimately) preventive, corrective or even therapeutic products based on microorganisms.